首页 | 本学科首页   官方微博 | 高级检索  
     


A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor,in Patients with Advanced Cancers
Authors:Anthony Tolcher  Keith Flaherty  Geoffrey I. Shapiro  Jordan Berlin  Thomas Witzig  Thomas Habermann  Andrea Bullock  Edwin Rock  Agnes Elekes  Chester Lin  Dusan Kostic  Naoto Ohi  Drew Rasco  Kyriakos P. Papadopoulos  Amita Patnaik  Lon Smith  Gregory M. Cote
Affiliation:1. South Texas Accelerated Research Therapeutics, San Antonio, Texas, USA;2. Massachusetts General Hospital, Boston, Massachusetts, USA;3. Dana‐Farber Cancer Institute, Boston, Massachusetts, USA;4. Vanderbilt‐Ingram Cancer Center, Nashville, Tennessee, USA;5. Mayo Clinic, Rochester, Minnesota, USA;6. Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA;7. Otsuka Pharmaceutical Development and Commercialization, Princeton, New Jersey, USA;8. Fujii Memorial Research Institute, Otsuka Pharmaceutical Co., Ltd., Otsu, Japan
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号